CELOX LABORATORIES INC
10QSB, EX-27, 2001-01-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CELOX LABORATORIES INC, 10QSB, 2001-01-12
Next: AMERICA ONLINE INC, 15-12G, 2001-01-12



<TABLE> <S> <C>


<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          AUG-31-2001
<PERIOD-END>                               NOV-30-2000
<CASH>                                         128,704
<SECURITIES>                                   435,867
<RECEIVABLES>                                   36,061
<ALLOWANCES>                                         0
<INVENTORY>                                     60,285
<CURRENT-ASSETS>                               683,169
<PP&E>                                         460,185
<DEPRECIATION>                                 361,797
<TOTAL-ASSETS>                                 832,531
<CURRENT-LIABILITIES>                          131,619
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        36,832
<OTHER-SE>                                     664,080
<TOTAL-LIABILITY-AND-EQUITY>                   832,531
<SALES>                                         48,719
<TOTAL-REVENUES>                                48,719
<CGS>                                           20,883
<TOTAL-COSTS>                                   45,816
<OTHER-EXPENSES>                               100,107
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,037
<INCOME-PRETAX>                               (70,280)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (70,280)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (70,280)
<EPS-BASIC>                                     (0.02)
<EPS-DILUTED>                                   (0.02)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission